SPOTLIGHT -
Out-of-hospital births increased adverse outcomes risk
Multiple studies have indicated a greater risk of neonatal morbidity and mortality when births occur in out-of-hospital settings.
Neurodevelopmental disorders from in utero COVID-19 exposure based on sex
In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.
Earlier HPV vaccination associated with completed vaccine series
In a recent review, children with vaccination against human papillomavirus (HPV) initialized at a younger age were more likely to receive their full vaccination series.
Butyrate effective for treating pediatric obesity
In a recent study, reductions in body mass index along with further beneficial effects were found when using oral butyrate supplementation for treating pediatric obesity.
Which drug products are abused by adolescents?
At the 44th National Association of Pediatric Nurse Practitioners Conference, drug products abused by teenagers were discussed.
Treating pediatric atopic dermatitis
At the 44th National Association of Pediatric Nurse Practitioners Conference, methods of treating atopic dermatitis were discussed.
Managing aggression in pediatric patients
At the 44th National Association of Pediatric Nurse Practitioners Conference, pediatric aggression was discussed, including which patients are at greater risk and which management strategies are most appropriate.
Choosing the right oral contraceptive
At the 44th National Association of Pediatric Nurse Practitioners Conference, guidelines for prescribing oral contraceptives were discussed.
Managing pregnancy in adolescents
At the 44th National Association of Pediatric Nurse Practitioners Conference, evidence-based approaches for supporting pregnant adolescents were discussed.
Highlighting pediatric nurse practitioners
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN, pediatric nurse practitioner, discusses the vital role of nurse practitioners and key takeaways from the 44th National Association of Pediatric Nurse Practitioners Conference.
How to manage viral infections in pediatric patients
At the 44th National Association of Pediatric Nurse Practitioners Conference, data was presented on the effectiveness of vaccines and antivirals in preventing life threatening conditions.
CDC immunization schedule updates
At the 44th National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule, detailing new changes.
Managing disordered eating in adolescents with type 1 diabetes
At the 44th National Association of Pediatric Nurse Practitioners Conference, a session presented data explaining why teenagers with type 1 diabetes were at high risk for developing anorexia and bulimia.
Diagnosing and treating PCOS in adolescents
At the 44th National Association of Pediatric Nurse Practitioners Conference, data was presented on how to diagnose and treat polycystic ovarian syndrome in adolescent patients.
SDX/d-MPH safe and effective against pediatric ADHD
In a recent study, positive safety and efficacy outcomes for serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH; Azstarys; KemPharm) were found in children aged 6 years and older with attention-deficit/hyperactivity disorder (ADHD).
CASSY tool effective in predicting adolescent suicide attempts
In a recent study, the Ask Suicide-Screening Questions (ASQ) and the Computerized Adaptive Screen for Suicidal Youth (CASSY) tools both showed predictive viability for suicide attempts in adolescents.
FDA approves trofinetide for treatment of Rett syndrome
The FDA has approved trofinetide (Daybue; Acadia Pharmaceuticals) for treating Rett syndrome in patients aged 2 years and older.
Treating pediatric obesity
In part 1 of our obesity series, Katherine H. Saunders, MD, DABOM, discusses methods of treating pediatric obesity, including medicines approved by the FDA and the advantages of Intellihealth.
COVID-19 vaccine effective against hospitalization from Omicron variant
In a recent study, children aged 5 to 11 years were less likely to be hospitalized with the Omicron strand if they received vaccination against COVID-19.
Penicillin allergy documentation uninformative in allergy tabs
In a recent study, penicillin allergy documentation was uninformative in allergy tabs, and children were not often referred to allergists.
Covis withdraws Makena from the market
Covis, the manufacturer of the controversial preterm birth prevention drug Makena, has announced it will voluntarily withdraw the drug from the market after recommendations from the Center for Drug Evaluation and Research.
E-cigarette use more common among sexual minority youth
In a recent study, the prevalence of e-cigarette use was greater among sexual minority youth than heterosexual or questioning youth.
Poor rate of outpatient care following mental health ED visit
In a recent study, a poor connection was reported between mental health emergency department discharge and follow-ups through outpatient care.
FDA accepts sNDA for empagliflozin in children with type 2 diabetes
A supplemental New Drug Application for empagliflozin (Jardiance; Boehringer Ingelheim and Eli Lilly and Company) in pediatric patients with type 2 diabetes has been accepted by the FDA.
The development of pediatric cardiovascular care
Anne Dubin, MD, division chief of pediatric cardiology at Stanford Medicine Children's Health, discusses developments made in pediatric cardiovascular care in recent decades, along with developments she hopes to see in the future.
Childhood respiratory infection linked to adult mortality
In a recent study, the risk of death from respiratory diseases during adulthood almost doubled in individuals who experienced a lower respiratory tract infection at a young age.
FDA accepts NDA for berdazimer gel to treat molluscum contagiosum
Following positive results from a phase 3 clinical trial, the FDA has accepted a New Drug Application for berdazimer gel, 10.3% (Novan) for treating patients with molluscum contagiosum.
Dupilumab sNDA accepted for chronic spontaneous urticaria in adolescents
A supplemental Biologics License Application has been accepted by the FDA for treating adolescents and adults with chronic spontaneous urticaria.
AAP: Reducing crowding in emergency departments
In a new policy statement, the American Academy of Pediatrics has provided guidelines on reducing crowding in emergency departments.
Violence encounters increase suicidal ideation among adolescents
In a recent study, the rate of suicidal ideation was 1.7 times greater among adolescents with depression who had experienced a violent encounter in the past year.